Immediate Impact

2 by Nobel laureates 53 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
2 intermediate papers

Works of Anja Bauerfeind being referenced

Association Screening in the Epidermal Differentiation Complex (EDC) Identifies an SPRR3 Repeat Number Variant as a Risk Factor for Eczema
2011
Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer
2000

Author Peers

Author Last Decade Papers Cites
Anja Bauerfeind 66 138 29 160 144 27 563
N. Stathakis 77 29 5 119 110 38 637
Risa Ebina‐Shibuya 16 61 5 159 86 25 645
Anjeni Keswani 15 31 3 72 74 28 515
Takahisa Takihara 12 41 145 231 25 586
H. F. Given 44 34 5 205 70 32 606
Yifeng Guo 13 198 10 138 20 37 568
Gabriele de Vos 20 73 4 69 61 27 493
Akiko Kawakita 11 19 10 163 152 29 639
Ravi Viswanathan 15 42 16 58 148 29 516
Zhiwei Xu 13 19 11 112 141 28 497

All Works

Loading papers...

Rankless by CCL
2026